This white paper is about leveraging T-cell receptor (TCR) repertoire analysis to assess the effectiveness of gene therapy strategies for DOCK8 deficiency. It demonstrates the use of ThinkBio®’s proprietary pipeline combining high-resolution TCR profiling with functional insights, enabling precise monitoring of immune recovery, making it a powerful tool for both research and clinical applications.